Position in ASND
as of Mar 31, 2026
· filed May 15, 2026
Position Value
$886,694,944
+$1,042,909 QoQ
Shares Held
3,876,601
-6.7% QoQ
Ownership
5.91%
of shares outstanding
% of Portfolio
0.05%
of 13F equity value
Holder Rank
—
not a current holder
Holding Since
Mar 2020
25 quarters on record
Voting authority
Sole 99.99600165196263.ToString("F0")%
Shared 0.ToString("F0")%
None 0.003998348037365723.ToString("F0")%
Common Shares in ASND Over Time
Shares Held
Position Value (USD)
Position in Biotechnology
Healthcare · as of Mar 31, 2026FMR LLC holds $49,674,888,413 across 352 Biotechnology names. ASND ranks #16 (1.8% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | ALNY |
Alnylam Pharmaceuticals, Inc.
|
14,579,166 | $4,823,808,652 | |
| 2 | ARGX |
Argenx SE
|
4,991,034 | $3,644,702,577 | |
| 3 | MRNA |
Moderna, Inc.
|
45,672,024 | $2,320,138,818 | |
| 4 | ROIV |
Roivant Sciences Ltd.
|
77,981,253 | $2,160,080,705 | |
| 5 | INSM |
INSMED Inc
|
13,160,167 | $2,151,950,504 | |
| 6 | IONS |
Ionis Pharmaceuticals Inc
|
24,556,637 | $1,843,957,869 | |
| 7 | RPRX |
Royalty Pharma plc
|
25,152,242 | $1,206,553,046 | |
| 8 | REGN |
Regeneron Pharmaceuticals, Inc.
|
1,518,192 | $1,173,015,865 |
All Filings in ASND
Export CSV
25 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-03-31 | $886,694,944 | 3,876,601 | Shares | Defined | 2026-05-15 | |
| 2025-12-31 | $885,652,035 | 4,153,311 | Shares | Defined | 2026-02-17 | |
| 2025-09-30 | $889,025,235 | 4,471,733 | Shares | Defined | 2025-11-13 | |
| 2025-06-30 | $782,175,561 | 4,531,724 | Shares | Defined | 2025-08-14 | |
| 2025-03-31 | $728,324,894 | 4,672,943 | Shares | Defined | 2025-05-12 | |
| 2024-12-31 | $650,992,830 | 4,728,647 | Shares | Defined | 2025-02-13 | |
| 2024-09-30 | $732,790,484 | 4,907,846 | Shares | Defined | 2024-11-13 | |
| 2024-06-30 | $671,338,048 | 4,922,555 | Shares | Defined | 2024-08-13 | |
| 2024-03-31 | $746,547,146 | 4,938,461 | Shares | Defined | 2024-05-13 | |
| 2023-12-31 | $644,154,774 | 5,114,369 | Shares | Defined | 2024-02-13 | |
| 2023-09-30 | $480,961,444 | 5,136,282 | Shares | Defined | 2023-11-13 | |
| 2023-06-30 | $458,816,845 | 5,140,805 | Shares | Defined | 2023-08-11 | |
| 2023-03-31 | $552,415,129 | 5,152,165 | Shares | Defined | 2023-08-11 | |
| 2022-12-31 | $638,626,318 | 5,229,070 | Shares | Defined | 2023-02-13 | |
| 2022-09-30 | $545,095,598 | 5,278,865 | Shares | Defined | 2022-11-10 | |
| 2022-06-30 | $492,048,433 | 5,293,120 | Shares | Defined | 2022-08-12 | |
| 2022-03-31 | $628,434,161 | 5,354,756 | Shares | Defined | 2022-05-13 | |
| 2021-12-31 | $720,535,010 | 5,355,943 | Shares | Defined | 2022-02-14 | |
| 2021-09-30 | $859,127,877 | 5,390,099 | Shares | Defined | 2022-02-14 | |
| 2021-06-30 | $708,125,361 | 5,382,937 | Shares | Defined | 2021-08-13 | |
| 2021-03-31 | $692,731,674 | 5,375,013 | Shares | Defined | 2021-05-14 | |
| 2020-12-31 | $890,873,548 | 5,341,609 | Shares | Defined | 2021-02-08 | |
| 2020-09-30 | $815,503,884 | 5,284,499 | Shares | Defined | 2020-11-13 | |
| 2020-06-30 | $709,710,424 | 4,798,583 | Shares | Defined | 2020-08-24 | |
| 2020-03-31 | $537,595,971 | 4,773,963 | Shares | Defined | 2020-05-14 | |
| No filing history on record for this holder in this stock. | ||||||